Logo

Aclara and Amersham Biosciences in Marketing Collaboration

Apr 02, 2003

NEW YORK, April 2 -- Aclara BioSciences and Amersham Biosciences today announced a joint marketing agreement for DNA analysis equipment and chemistries.

 

Financial details were not provided.

 

The non-exclusive agreement joins Amersham Biosciences MegaBace DNA analysis system, and Alcara's eTag assay system, as complementary systems. The companies will continue to sell and support the systems independently, but will promote the other's products for their respective platforms.

Breaking News
The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.